Results 71 to 80 of about 2,216,425 (306)
Clinical Course and Impact of Breaks in Therapy for Children With Relapsed/Refractory Solid Tumors
ABSTRACT Introduction Pediatric relapsed or refractory (R/R) solid tumors carry a dismal prognosis, and postrelapse patient experiences are not well described. We present postrelapse outcomes, including number of R/R events and subsequent therapy regimens.
Matthew T. McEvoy +5 more
wiley +1 more source
Improving transparency and scientific rigor in academic publishing. [PDF]
Progress in basic and clinical research is slowed when researchers fail to provide a complete and accurate report of how a study was designed, executed, and the results analyzed.
Alberts +94 more
core +3 more sources
ABSTRACT Background Neuropsychological complications may impair the qualitative prognosis of patients with pediatric brain tumors. However, multifaceted evaluations cannot be conducted in all patients because they are time consuming and burdensome for patients.
Ami Tabata +9 more
wiley +1 more source
Background N-of-1 trials are multiple cross-over trials done in individual participants, generating individual treatment effect information. While reporting guidelines for the CONSORT Extension for N-of-1 trials (CENT) and the Standard Protocol Items ...
Antony J. Porcino +7 more
doaj +1 more source
Measuring Operations: An Analysis of the Financial Statements of U.S. Private Colleges and Universities [PDF]
As events in the business sector have highlighted, companies can play by the rules and yet produce misleading financial statements. This study examines the nongovernmental organizations that provide a substantial portion of higher education in the United
Elizabeth K. Keating +3 more
core +1 more source
ABSTRACT Background Patients with high‐risk neuroblastoma who either are refractory to induction chemotherapy or relapse following multi‐modal treatment have a dismal prognosis. Based on data from the BEACON trial, since 2021 the UK national guidelines recommend bevacizumab, irinotecan, and temozolomide (BIT) for patients with relapsed/refractory ...
Thomas J. Jackson +20 more
wiley +1 more source
BankCaR (Bank Capital-at-Risk): A credit risk model for US commercial bank charge-offs [PDF]
BankCaR is a credit risk model that forecasts the distribution of a commercial bank's charge-offs. The distribution depends only on systematic factors; BankCaR takes each bank and projects its expected charge-off across a distribution of good years and ...
Frye, Jon, Pelz, Eduard
core +1 more source
IMPLEMENTATION OF IPSAS 23 "REVENUE FROM NON-EXCHANGE TRANSACTIONS (TAXES AND TRANSFERS)" IN ROMANIA: THEORETICAL APPROACH FOR LOCAL PUBLIC ADMINISTRATION [PDF]
In recent decades, governments and public institutions around the world have recognized the need to improve transparency and accountability in the management of public resources.
CIUREA MARIA
doaj
Estimating the sample mean and standard deviation from commonly reported quantiles in meta-analysis
Researchers increasingly use meta-analysis to synthesize the results of several studies in order to estimate a common effect. When the outcome variable is continuous, standard meta-analytic approaches assume that the primary studies report the sample ...
Benedetti, Andrea +6 more
core
ABSTRACT Background Parents of children treated for acute lymphoblastic leukemia (ALL) often experience significant caregiver burden and disruption to their well‐being. While parent quality of life (QoL) during treatment is well characterized, little is known about outcomes during early survivorship.
Sara Dal Pra +3 more
wiley +1 more source

